Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Plasmodium falciparum infections adversely affect pregnancy. Anti-malarial treatment failure is common. The objective of this study was to examine the duration of persistent parasite carriage following anti-malarial treatment in pregnancy. METHODS: The data presented here are a collation from previous studies carried out since 1994 in the Shoklo Malaria Research Unit (SMRU) on the Thailand-Myanmar border and performed using the same unique methodology detailed in the Materials and Methods section. Screening for malaria by microscopy is a routine part of weekly antenatal care (ANC) visits and therapeutic responses to anti-malarials were assessed in P. falciparum malaria cases. Women with microscopy confirmed P. falciparum malaria had a PCR blood spot from a finger-prick sample collected. Parasite DNA was extracted from the blood-spot samples using saponin lysis/Chelex extraction method and genotyped using polymorphic segments of MSP1, MSP2 and GLURP. Recurrent infections were classified by genotyping as novel, recrudescent or indeterminate. Factors associated with time to microscopy-detected recrudescence were analysed using multivariable regression techniques. RESULTS: From December 1994 to November 2009, 700 women were treated for P. falciparum and there were 909 recurrent episodes (481 novel and 428 recrudescent) confirmed by PCR genotyping. Most of the recurrences, 85% (770/909), occurred after treatment with quinine monotherapy, artesunate monotherapy or artesunate-clindamycin. The geometric mean number of days to recurrence was significantly shorter in women with recrudescent infection, 24.5 (95%: 23.4-25.8), compared to re-infection, 49.7 (95%: 46.9-52.7), P<0.001. The proportion of recrudescent P. falciparum infections that occurred after days 28, 42 and 63 from the start of treatment was 29.1% (124/428), 13.3% (57/428) and 5.6% (24/428). Recrudescent infections≥100 days after treatment occurred with quinine and mefloquine monotherapy, and quinine+clindamycin and artesunate+atovaquone-proguanil combination therapy. Treatments containing an artemisinin derivative or an intercalated Plasmodium vivax infection increased the geometric mean interval to recrudescence by 1.28-fold (95% CI: 1.09-1.51) and 2.19-fold (1.77-2.72), respectively. Intervals to recrudescence were decreased 0.83-fold (0.73-0.95) if treatment was not fully supervised (suggesting incomplete adherence) and 0.98-fold (0.96-0.99) for each doubling in baseline parasitaemia. CONCLUSIONS: Prolonged time to recrudescence may occur in pregnancy, regardless of anti-malarial treatment. Long intervals to recrudescence are more likely with the use of artemisinin-containing treatments and also observed with intercalated P. vivax infections treated with chloroquine. Accurate determination of drug efficacy in pregnancy requires longer duration of follow-up, preferably until delivery or day 63, whichever occurs last.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nosten, F., van Vugt, M., Price, R., Luxemburger, C., Thway, K., Brockman, A., McGready, R., ter Kuile, F., Looareesuwan, S., & White, N. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02505-8 · Cited by 500
Self-citationThe epidemiology of severe malaria in an area of low transmission in Thailand.
Luxemburger, C., Ricci, F., Nosten, F., Raimond, D., Bathet, S., & White, N. J. (1997) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(97)90066-3 · Cited by 299 · cited 3×
“Acquired immunity is poorly protective and severe malaria is common at all ages, especially in pregnant women [22].”
BackgroundInfluentialSelf-citationMalaria during pregnancy in an area of unstable endemicity.
Nosten, F., ter Kuile, F., Maelankirri, L., Decludt, B., & White, N. J. (1991) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(91)90205-d · Cited by 294 · cited 4×
“Treatment of these episodes reduces but does not eliminate the adverse effects of low birth weight for the foetus and anaemia for the mother [2], which can only be achieved by prevention.”
BackgroundInfluentialSelf-citationBrockman, A., Price, R. N., van Vugt, M., Heppner, D. G., Walsh, D., Sookto, P., Wimonwattrawatee, T., Looareesuwan, S., White, N. J., & Nosten, F. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90080-4 · Cited by 185 · cited 1×
“falciparum isolates in this area are amongst the highest reported in the world [35, 36] some isolates are still partially sensitive to chloroquine.”
BackgroundSelf-citationMcGREADY, R., DAVISON, B. B., STEPNIEWSKA, K., CHO, T., SHEE, H., BROCKMAN, A., UDOMSANGPETCH, R., LOOAREESUWAN, S., WHITE, N. J., MESHNICK, S. R., et al. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.70.398 · Cited by 170 · cited 1×
“Immunity to malaria is reduced in pregnancy and the placenta provides a favourable site for the parasite to sequester where host defence mechanisms are attenuated [34].”
BackgroundSelf-citationMcGready, R., Tan, S. O., Ashley, E. A., Pimanpanarak, M., Viladpai-nguen, J., Phaiphun, L., Wüstefeld, K., Barends, M., Laochan, N., Keereecharoen, L., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050253 · Cited by 136 · cited 1×
“In pregnancy, when a woman may naturally follow antenatal care for an extended period, much longer carriage times have been reported: 133 days in Malawi [14], 187 days in Mozambique [15], 85 days [7], 98 days [10] and 121 days [3] on the Thailand-Myanmar border.”
BackgroundSelf-citationMcGready, R., Cho, T., Samuel, Villegas, L., Brockman, A., van Vugt, M., Looareesuwan, S., White, N. J., & Nosten, F. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90106-3 · Cited by 114 · cited 8×
“DHA + Piperaquine (long, 2006–2008) 29 20 [8–34] 23 63 [35–180] 6 33 [21–49] 66.”
MethodInfluentialSelf-citationMcGready, R., Ashley, E. A., Moo, E., Cho, T., Barends, M., Hutagalung, R., Looareesuwan, S., White, N. J., & Nosten, F. (2005) · The Journal of Infectious Diseases · doi:10.1086/432551 · Cited by 112 · cited 1×
“The proportion of recrudescent infections with quinine and mefloquine monotherapy was high and these poorly efficacious regimens should no longer be used in this area [6, 7].”
BackgroundSelf-citationMcGready, R., Brockman, A., Cho, T., Cho, D., van Vugt, M., Luxemburger, C., Chongsuphajaisiddhi, T., White, N. J., & Nosten, F. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90235-9 · Cited by 110 · cited 2×
“The proportion of recrudescent infections with quinine and mefloquine monotherapy was high and these poorly efficacious regimens should no longer be used in this area [6, 7].”
BackgroundSelf-citationObstetric ultrasound scanning by local health workers in a refugee camp on the Thai-Burmese border.
Rijken, M. J., Lee, S. J., Boel, M. E., Papageorghiou, A. T., Visser, G. H. A., Dwell, S. L. M., Kennedy, S. H., Singhasivanon, P., White, N. J., Nosten, F., et al. (2009) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.7350 · Cited by 108
Self-citation
Research works printed but not linked: 25
- Brockman A, Paul RE, Anderson TJ, Hackford I, Phaiphun L, Looareesuwan S, et al. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am J Trop MedHyg. 1999;60:14–21. · DOI · Paper page
- Stepniewska K, Taylor WR, Mayxay M, Price R, Smithuis F, Guthmann JP, et al. In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother. 2004;48:4271–80. · DOI
- Farnert A, Arez AP, Babiker HA, Beck HP, Benito A, Bjorkman A, et al. Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Trans R Soc Trop Med Hyg. 2001;95:225–32. · DOI · Paper page
- Rijken MJ, McGready R, Boel ME, Barends M, Proux S, Pimanpanarak M, et al. Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report. Am J Trop Med Hyg. 2008;78:543–5. · DOI · Paper page
- Nosten F, Brasseur P. Combination therapy for malaria: the way forward? Drugs. 2002;62:1315–29. · DOI
- Nosten F, White NJ. Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007;77:181–92. · DOI · Paper page
- Ashley EA, White NJ. The duration of Plasmodium falciparum infections. Malar J. 2014;13:500. · DOI · Paper page
- Eyles DE, Young MD. The duration of untreated or inadequately treated Plasmodium falciparum infections in the human host. J Natl Malar Soc. 1951;10:327–36.
- Jeffery GM, Eyles DE. The duration in the human host of infections with a Panama strain of Plasmodium falciparum. Am J Trop Med Hyg. 1954;3:219–24. · DOI · Paper page
- Farnert A, Arez AP, Correia AT, Bjorkman A, Snounou G, do Rosario V. Sampling and storage of blood and the detection of malaria parasites by polymerase chain reaction. Trans R Soc Trop Med Hyg. 1999;93:50–3. · DOI
- Kain KC, Lanar DE. Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood. J Clin Microbiol. 1991;29:1171–4. · DOI · Paper page
- Covell G. Relationship between malarial parasitaemia and symptoms of the disease: a review of the literature. Bull World Health Organ. 1960;22:605–19.
- WHO. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva: World Health Organization; 2003. p. 57.
- Dubowitz LM, Dubowitz V, Goldberg C. Clinical assessment of gestational age in the newborn infant. J Pediatr. 1970;77:1–10. · DOI · Paper page
- Paul RE, Brockman A, Price RN, Luxemburger C, White NJ, Looareesuwan S, et al. Genetic analysis of Plasmodium falciparum infections on the north-western border of Thailand. Trans R Soc Trop Med Hyg. 1999;93:587–93. · DOI
- Snounou G, Beck HP. The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. Parasitol Today. 1998;14:462–7. · DOI · Paper page
- Villegas L, McGready R, Htway M, Paw MK, Pimanpanarak M, Arunjerdja R, et al. Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double-blind, placebo-controlled trial. Trop Med Int Health. 2007;12:209–18. · DOI · Paper page
- Hoshen MB, Na-Bangchang K, Stein WD, Ginsburg H. Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of ‘dormancy’, a partial cytostatic effect of the drug, and its implication for treatment regimens. Parasitology. 2000;121:237–46. · doi:10.1017/s0031182099006332
- Teuscher F, Gatton ML, Chen N, Peters J, Kyle DE, Cheng Q. Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure. J Infect Dis. 2010;202:1362–8. · DOI · Paper page
- Nakazawa S, Kanbara H, Aikawa M. Plasmodium falciparum: recrudescence of parasites in culture. Exp Parasitol. 1995;81:556–63. · doi:10.1006/expr.1995.1149
- Thapar MM, Gil JP, Bjorkman A. In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil. Trans R Soc Trop Med Hyg. 2005;99:62–70. · DOI
- Barends M, Jaidee A, Khaohirun N, Singhasivanon P, Nosten F. In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border. Malar J. 2007;6:81. · DOI
- Nosten F, Rogerson SJ, Beeson JG, McGready R, Mutabingwa TK, Brabin B. Malaria in pregnancy and the endemicity spectrum: what can we learn? Trends Parasitol. 2004;20:425–32. · DOI · Paper page
- Nosten F, McGready R, Mutabingwa T. Case management of malaria in pregnancy. Lancet Infect Dis. 2007;7:118–25. · DOI
- Lwin KM, Phyo AP, Tarning J, Hanpithakpong W, Ashley EA, Lee SJ, et al. Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria. Antimicrob Agents Chemother. 2012;56:1571–7. · DOI
Cited by
Moore, K. A., Simpson, J. A., Wiladphaingern, J., Min, A. M., Pimanpanarak, M., Paw, M. K., Raksuansak, J., Pukrittayakamee, S., Fowkes, F. J. I., White, N. J., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0877-6 · Cited by 111
“Genotyping data were not available to classify recurrent episodes, which could be either novel, recrudescent, or a relapse in the case of vivax malaria [28].”
BackgroundSelf-citationMoore, K. A., Simpson, J. A., Paw, M. K., Pimanpanarak, M., Wiladphaingern, J., Rijken, M. J., Jittamala, P., White, N. J., Fowkes, F. J. I., Nosten, F., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00547-2 · Cited by 84
Self-citationCurrent update on malaria in pregnancy: a systematic review
Minwuyelet, A., Yewhalaw, D., Siferih, M., & Atenafu, G. (2025) · Tropical Diseases, Travel Medicine and Vaccines · doi:10.1186/s40794-025-00248-1 · Cited by 49
Cohort Profile: the SMRU Refugee and Migrant Pregnancy Study in Western Thailand and Eastern Myanmar
McGready, R., J White, N., Nosten, F. H., & Collaborators, S. R. A. M. P. S. (2026) · Wellcome Open Research · doi:10.12688/wellcomeopenres.25582.2 · Cited by 2
Self-citation
Metadata
- Authors
- Laochan, N., Zaloumis, S. G., Imwong, M., Lek-Uthai, U., Brockman, A., Sriprawat, K., Wiladphaingern, J., White, N. J., Nosten, F., & McGready, R.
- Venue
- Malaria Journal
- Published
- 2015-05-28
- Volume
- 14
- Issue
- 1
- Pages
- 221-221
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W1759311365
- Cited by
- 20
- References
- 15
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- Funders
- Wellcome Trust of Great Britain Major Overseas Programme–Thailand Unit Core Grant (ID0E1WAE417)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort. https://app.cochat.ai/papers/10.1186/s12936-015-0745-9
- The paper
- Laochan, N., Zaloumis, S. G., Imwong, M., Lek-Uthai, U., Brockman, A., Sriprawat, K., Wiladphaingern, J., White, N. J., Nosten, F., & McGready, R. (2015). Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort. Malaria Journal. https://doi.org/10.1186/s12936-015-0745-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.